Current Prurigo Nodularis trials:
AMGEN:
A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis
Current Prurigo Nodularis trials:
AMGEN:
A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis